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Neutrophil extracellular trap formation requires
OPA1-dependent glycolytic ATP production
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Optic atrophy 1 (OPA1) is a mitochondrial inner membrane protein that has an important role
in mitochondrial fusion and structural integrity. Dysfunctional OPA1 mutations cause atrophy
of the optic nerve leading to blindness. Here, we show that OPA1 has an important role in the
innate immune system. Using conditional knockout mice lacking Opa1 in neutrophils
(Opa1NΔ), we report that lack of OPA1 reduces the activity of mitochondrial electron
transport complex I in neutrophils. This then causes a decline in adenosine-triphosphate
(ATP) production through glycolysis due to lowered NAD+ availability. Additionally, we show
that OPA1-dependent ATP production in these cells is required for microtubule network
assembly and for the formation of neutrophil extracellular traps. Finally, we show that Opa1NΔ
mice exhibit a reduced antibacterial defense capability against Pseudomonas aeruginosa.
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Besides intracellular killing, neutrophils are able to exert anantibacterial activity in the extracellular space by the for-mation of so-called neutrophil extracellular traps (NETs)1,2.
NETs consist of DNA and granule proteins and are able to bind
and to kill extracellular pathogens. Thus, NETs represent an
important element of the innate immune response and they are
seen in association with many infectious, allergic, and auto-
immune diseases3–5. It should be noted that such extracellular
DNA traps able to kill bacteria can also be formed by eosinophils6
and basophils7. Although the functional importance of NETs is
generally accepted, the origin of the DNA scaffold in NETs, as
well as the mechanism of their generation, remains unclear and a
matter of dispute.
Since we had observed that neutrophils and other granulocytes
release mitochondrial DNA (mtDNA) in the formation of
extracellular DNA traps3, we hypothesized that mitochondrial
dynamics might be important for mtDNA release. Five members
of the GTPase dynamin family, namely mitofusin-1 (MFN1),
mitofusin-2 (MFN2), optic atrophy 1 (OPA1), mitochondrial
ﬁssion 1 (FIS1), and dynamin-related protein 1 (DRP1) are
known as the “mitochondria-shaping” proteins which regulate
the fusion and ﬁssion of mitochondria8. OPA1 is anchored to the
mitochondrial inner membrane, and, together with MFN1 and
MFN2, which are located in the outer mitochondrial membrane,
it controls the mitochondrial fusion process9. Interestingly, and
independent of its role in mitochondrial fusion, OPA1 is also
responsible for maintaining the mitochondrial cristae junctions
tight, thus allowing efﬁcient oxidative respiration10–12. Genetic
depletion of OPA1 resulted in reduced cell growth and lowered
mitochondrial membrane potential, as well as in defective cellular
respiration and metabolism13,14. Patients with mutated OPA1 can
develop autosomal dominant optic atrophy (ADOA), which leads
to loss of bilateral visual function within the ﬁrst two decades of
life, or may present with additional signs of peripheral neuro-
pathy, deafness, cerebellar ataxia, paraparesis, and myopathy15,16.
Reduction of OPA1 activity has also been associated with other
neurodegenerative diseases, such as Alzheimer, Huntington, and
Parkinson diseases17.
In this paper, we demonstrate that the lack of OPA1, or
mutations in the OPA1 gene, can also result in functional defects
outside of the nervous system. Speciﬁcally, we show that OPA1 is
required for ATP production through glycolysis in neutrophils,
cells which are known to contain a modest number of mito-
chondria, but are unable to perform mitochondrial respiration18.
ATP production in neutrophils is required for the assembly of the
microtubule network. Furthermore, this network has recently
been demonstrated to be essential for NET production19. Neu-
trophils lacking other members of GTPase dynamin family
exhibit no such defect in NET formation, suggesting that the
OPA1 effects on neutrophils are a consequence of its role in
maintaining the mitochondrial cristae junctions tight and thus
likely to be independent of mitochondrial fusion. Moreover, mice
with Opa1 knockout neutrophils demonstrate defects in anti-
bacterial defense owing to their inability to form NETs under
in vivo conditions. Taken together, the ﬁndings presented here
provide a signiﬁcant step forward in understanding OPA1
mitochondrial functions in non-neuronal cells and extend the
impact of these functions to the innate immune system.
Results
OPA1-deﬁcient neutrophils are unable to form NETs. To test
whether members of GTPase dynamin family are involved in the
process of extracellular DNA release from neutrophils, we used a
small hairpin RNA (shRNA)-based approach. To this end, len-
tivirus particles containing ﬁve different human shRNA
sequences for each candidate gene, namely; DRP1, FIS1, MFN1,
MFN2, and OPA1 (Mission shRNA, Sigma-Aldrich) were trans-
duced into human myeloid leukemia cells (PLB-985). Similarly,
mouse shRNAs were used in Hoxb8-immortalized mouse pro-
genitor cells (Hoxb8 neutrophils)20. After antibiotic selection and
cloning of single cells, transduced clones were tested for the
down-regulation of target genes using qPCR (Supplementary
Fig. 1a, b, left panels). Cells with the lowest expression of target
genes were differentiated to mature neutrophils and examined for
their ability to release DNA following GM-CSF priming and
subsequent C5a stimulation21. Reduction of OPA1 mRNA
expression, but not any of the other dynamin-like GTPases, was
associated with a complete inability to release DNA with either
differentiated human myeloid leukemia cells or mouse Hoxb8
neutrophils (Supplementary Fig. 1a, b, right panels).
To verify the relevance of OPA1 for DNA release and NET
formation in primary human neutrophils, we isolated blood
neutrophils from two patients of the same family (father and
son), both suffering from autosomal dominant optic atrophy
disease (ADOA). They harbor the heterozygous synonymous
mutation c.1140G>A/ p.(Glu380Glu) resulting in exon 11 skip-
ping in the original isoform identiﬁed (NM_015560.2) (Fig. 1a)22.
While the neutrophils of the father released extracellular DNA
following combined GM-CSF/C5a stimulation in the same way as
control neutrophils, activation of neutrophils from the son failed
to cause DNA release (Fig. 1b), in spite of their similar level of
OPA1 protein expression (Fig. 1c). Although it remains unclear
why the neutrophils of father and son behaved differently, we
concluded that mutated OPA1 can result in a functional defect
with respect to extracellular DNA release in primary human
neutrophils.
It has been speculated that an OPA1 deﬁciency might cause
mtDNA instability in neurons, leading to reduced mtDNA
levels23,24. To test this hypothesis, we compared the mtDNA
content by analyzing the levels of the mitochondrial gene ATP
synthase protein 8 (MT-ATP8) and the mitochondrial D-loop
region compared to the single copy β2 microglobulin (B2M)
nuclear gene25 and observed no differences between neutrophils
of ADOA patients and healthy controls (Fig. 1d). These ﬁndings
are in agreement with a previous report demonstrating that white
blood cells of ADOA patients exhibit a normal content of
mtDNA26. Therefore, it seems unlikely that the failure to release
DNA in OPA1 defective neutrophils is the consequence of
reduced mtDNA levels.
Since ADOA exhibits heterogeneous phenotypes12,27 and as it
is a rare disease, making it difﬁcult to obtain primary neutrophils
from patients, we pursued a genetic approach to investigate more
closely the role of OPA1 in DNA release and NET formation.
Mouse and ﬂy models that carry homozygous Opa1mutations are
embryonically lethal28. Therefore, we generated Opa1ﬂox/ﬂox-
Lyz2Cre/Cre mice (designated Opa1NΔ mice hereafter) to study the
effects of Opa1 deﬁciency in neutrophils (Supplementary Fig. 2a).
Mature bone marrow neutrophils of Opa1NΔ mice displayed a
complete OPA1 knockout at the protein level (Supplementary
Fig. 2b). In contrast to neutrophils from control Lyz2Cre/Cre mice,
Opa1NΔ primary mouse neutrophils did not exhibit any
detectable DNA release upon GM-CSF priming and activation
with C5a, with LPS treatment, or following co-culture with E.
coli–GFP (Fig. 1e, left panel). To quantify the dsDNA released by
activated neutrophils, we collected the culture supernatants and
measured the amount released in the supernatant using Pico-
Green ﬂuorescent dye. In contrast to Lyz2Cre/Cre mice, neutro-
phils derived from Opa1NΔ mice were unable to release dsDNA
upon activation (Fig. 1e, right panel). We also tested other
activating reagents previously reported to induce NET formation
such as PMA, P. aeruginosa in co-culture, or nucleic
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Fig. 1 Failure of DNA release by OPA1-deﬁcient human and mouse neutrophils. a Molecular characterization of OPA1 transcripts in ADOA patients. OPA1
transcript analysis from isolated neutrophils encompassing exons 10–12 derived from a control and two ADOA patients harboring the heterozygous
c.1140G>A mutation (NM_015560.2). A shortened product of 334 bp reveals the aberrantly spliced, skipped exon 11 and is detected in patients’ cDNA
only. The band of 409 bp indicates the wild-type transcript. A full image of the agarose gel is provided in Supplementary Fig. 11a. b Confocal microscopy.
Highly puriﬁed human blood neutrophils from control individuals and two ADAO patients were primed with GM-CSF and subsequently stimulated with
C5a. Extracellular DNA was stained with MitoSOX™ Red and the nucleus with Hoechst 33342 (blue). Bars, 10 μm. Right: Quantiﬁcation of the number of
DNA-releasing neutrophils. Values are means ± SEM. **p < 0.01; n= 3. c Immunoblotting. Protein lysates of freshly isolated neutrophils from ADOA
patients and healthy donors were analyzed for OPA1 protein expression. Full-length immunoblots are provided in Supplementary Fig. 11b. d Quantitative
PCR. Genomic DNA from freshly puriﬁed human neutrophils of ADOA patients and healthy control donors were analyzed for mtDNA content (average of
ATP synthase protein 8 (MT-ATP8) and mitochondrial D-Loop) per single copy nuclear gene (B2M). Values are means ± SEM (n= 3). e Confocal
microscopy. Primary mature neutrophils from Opa1NΔ and control mice were primed with GM-CSF and subsequently stimulated with C5a, LPS, or co-
cultured with E. coli–GFP. Extracellular DNA was stained with MitoSOX™ Red and the nucleus with Hoechst 33342 (blue). Bars, 10 μm. Right: quantiﬁcation
of released dsDNA in supernatants of activated neutrophils. Values are means ± SEM. n.s., not signiﬁcant; **p < 0.01; ***p < 0.001; n= 5. Additional data
including NET formation induced by other triggers are provided in Supplementary Fig. 2c
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acid–containing immune complexes (ICs) produced by combin-
ing the small nuclear ribonucleoprotein (smRNP) antigen with
either SLE sera (RNP ICs-SLE) or with anti-damaged-DNA/RNA
antibody (RNP-ICs-Ab)29. None of these stimuli could trigger
NET formation in Opa1NΔ neutrophils (Supplementary Fig. 2c).
To exclude any effect of Cre recombinase on extracellular DNA
release, we also analyzed Opa1ﬂox/ﬂox neutrophils and observed
no difference as compared to Lyz2Cre/Cre neutrophils (Supple-
mentary Fig. 2d).
We next investigated functional consequences of the lack of
DNA release in Opa1NΔ neutrophils in terms of NET formation.
Since granule proteins are essential components of NETs2,21,30,
we performed immunoﬂuorescence microscopy studies in which
we searched for the presence of elastase within the released DNA
scaffold of activated mouse neutrophils. In activated control
Lyz2Cre/Cre neutrophils, we found extracellular DNA ﬁbers co-
localizing with elastase (Supplementary Fig. 2e). In contrast, with
Opa1NΔ neutrophils, we were unable to detect elastase-containing
extracellular structures.
In summary, we report that neutrophilic cell lines and primary
human or mouse neutrophils deﬁcient in functional OPA1 are
unable to form the extracellular DNA scaffolds as seen in NETs.
OPA1-deﬁcient neutrophils exhibit disruption of the micro-
tubule network. Mitochondrial localization analysis revealed a
wide distribution in the cytoplasm of resting Opa1NΔ neutrophils,
whereas in control Lyz2Cre/Cre neutrophils, mitochondria were
concentrated in the perinuclear region (Supplementary Fig. 3a).
Following combined GM-CSF/C5a stimulation of control neu-
trophils, the vast majority of mitochondria translocated toward
the plasma membrane. In contrast, in stimulated Opa1NΔ neu-
trophils, mitochondria remained widely distributed showing no
change in location (Supplementary Fig. 3a). This ﬁnding points to
a possible defect in microtubule network dynamics31. Further
suggestive of a microtubule defect is the observation that stimu-
lated Opa1NΔ neutrophils also exhibit a failure in degranulation
(Supplementary Fig. 3b, c), a process which is known to be
dependent on microtubule assembly32.
Therefore, we investigated the microtubule network in control
Lyz2Cre/Cre and Opa1NΔ neutrophils following activation and
observed a disrupted microtubule network associated with OPA1
deﬁciency (Fig. 2a). Quantiﬁcation of the microtubule network
assembly demonstrated signiﬁcant differences between Opa1NΔ
neutrophils compared to Opa1ﬂox/ﬂox and Lyz2Cre/Cre control
neutrophils following GM-CSF/C5a stimulation (Supplementary
Fig. 4a, b). Reduced microtubule network formation in Opa1NΔ
neutrophils was also observed following activation with GM-CSF/
RNP ICs-Ab, GM-CSF/RNP ICs-SLE, PMA, or P. aeruginosa as
compared to activated Lyz2Cre/Cre control neutrophils (Supple-
mentary Fig. 4c). Inhibition of the microtubule network
formation was also observed in human neutrophils expressing
functionally inactive OPA1 (Fig. 2b). A quantitative analysis
demonstrates that OPA1-defective human neutrophils are unable
to assemble the microtubule network following combined GM-
CSF/C5a stimulation (Supplementary Fig. 5a). To investigate the
role of the microtubule network in DNA release, we used
nocodazole and taxol, both known as highly efﬁcient
microtubule-disrupting agents33. As previously reported19, both
drugs completely prevented the formation of the microtubule
network (Fig. 2c) as well as interdicting DNA release in
stimulated normal human neutrophils (Fig. 2d). Taken together,
these results indicate that OPA1 regulates microtubule network
assembly which is required for the translocation of mitochondria,
for degranulation, and for DNA release in activated mouse and
human neutrophils.
On the other hand, Opa1NΔ neutrophils exhibited normal
production of reactive oxygen species (ROS) upon stimulation,
excluding the possibility that OPA1 regulates the NADPH
oxidase which is required for NET formation (Supplementary
Fig. 4d)2,34. In addition, Opa1NΔ neutrophils showed no
abnormality with regard to actin polymerization upon activation
(Supplementary Fig. 4e). Normal actin polymerization was also
observed in human neutrophils expressing functionally inactive
OPA1 (Supplementary Fig. 5b), conﬁrming the ﬁndings obtained
with primary mouse neutrophils. Summarizing, OPA1-deﬁcient
neutrophils are unable to form a microtubule network, but exhibit
normal ROS production and actin polymerization under the same
activation conditions.
OPA1-deﬁcient neutrophils exhibit decreased ATP production.
Super-resolution microscopy allowed us to clearly visualize a
mitochondrial fragmentation in Opa1NΔ neutrophils that was not
seen in DNA-releasing control Lyz2Cre/Cre neutrophils in which
mitochondria remained interconnected (Fig. 2a). Moreover, in
contrast to normal human neutrophils that exhibit long ﬁla-
mentous mitochondria in the absence of stimulus, we also
observed mitochondrial fragmentation in neutrophils of ADOA
patients in both activated and resting conditions (Fig. 2b). These
ﬁndings conﬁrm previously published work suggesting a role for
OPA1 in mitochondrial fusion11.
It has been reported that the tightness of cristae junctions
correlates with oligomerization of OPA110,11. On the other hand,
genetic depletion of OPA1 leads to disorganization of the cristae,
resulting in problems with its assembly and with the stability of
respiratory chain complexes and mitochondrial respiratory
function10,35. To image mitochondria in Opa1NΔ neutrophils,
we used conventional transmission electron microscopy (TEM).
While the number of mitochondria appeared to be independent
of OPA1 expression (Fig. 3a, b), a ﬁnding which was supported by
our mtDNA measurements (Fig. 3c), we also investigated
mitochondrial transcription factor A (TFAM) expression as a
measure of mtDNA levels. Equal levels of TFAM expression in
control and Opa1NΔ neutrophils were observed (Fig. 3d), also
conﬁrming indirectly that the mtDNA levels are unchanged in
the absence of OPA1. Morphometric analysis revealed a
diminished average mitochondrial length (Fig. 3a, e) and an
increased width of the cristae (Fig. 3a, f) in Opa1NΔ compared to
Lyz2Cre/Cre neutrophils. Upon combined GM-CSF/C5a stimula-
tion, the number of mitochondria increased owing to ﬁssion to a
smaller average size in control neutrophils, while in Opa1NΔ
neutrophils, the number and size of mitochondria did not change
signiﬁcantly (Fig. 3a and Supplementary Fig. 6).
The increased width of the cristae as a consequence of OPA1
ablation is believed to be associated with an impaired respiration
complex35. In addition, previously published work reported that
muscle cells from adult ADOA patients displayed reduced
ATP synthesis, suggesting dysregulation of mitochondrial meta-
bolism as a consequence of OPA1 dysfunction36. Therefore, we
analyzed the total cellular ATP level in Opa1NΔ neutrophils and
observed a reduction as compared to Lyz2Cre/Cre neutrophils
(Fig. 3g).
Complex I activity regulates neutrophil glycolysis and func-
tions. To test whether diminished ATP levels could contribute to
the disruption of the microtubule network and the failure of DNA
release, exogenous ATP or nicotinamide mononucleotide (NMN;
to rescue NAD+ levels, see below) was added to the cells 30 min
before physiological activation of the neutrophils with GM-CSF/
C5a. Indeed, addition of exogenous ATP or NMN were able
to restore the ability of Opa1NΔ neutrophils to form a normal
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Fig. 2 Absence of microtubule formation in OPA1-deﬁcient human and mouse neutrophils. a Super-resolution microscopy. Microtubule formation and
mitochondrial morphology of primary mature neutrophils from Opa1NΔ and control mice following GM-CSF priming and subsequent C5a stimulation.
Microtubules were stained with anti-α-tubulin antibody (green), the nucleus with Hoechst 33342 (blue) and mitochondria with MitoTracker® Orange
(red). Images were acquired by ELYRA super-resolution microscopy. Bars, 10 µm. The data are representative of three independent experiments.
Quantiﬁcation and additional data including microtubule formation induced by other triggers are provided in Supplementary Fig. 4a–c. b Super-resolution
microscopy. Microtubule formation and mitochondrial morphology in human blood neutrophils from control individuals and an ADAO patient (son, see
Fig. 1) following GM-CSF priming and subsequent C5a stimulation. Microtubules were stained with anti-α-tubulin antibody (green), the nucleus with
Hoechst 33342 (blue) and mitochondria with MitoTracker® Orange (red). Single cells are shown at higher magniﬁcation in the insets. Images were
acquired by ELYRA super-resolution microscopy. Bars, 10 µm. The data are representative of three independent experiments. Quantiﬁcation is provided in
Supplementary Fig. 5a. c Confocal microscopy. Microtubule assembly was analyzed in human control neutrophils following pre-treatment with the
indicated inhibitors and subsequent combined GM-CSF/C5a stimulation. Microtubules were stained with anti-α-tubulin antibody (red), the nucleus with
Hoechst 33342 (blue). Bars, 10 µm. Right: Quantiﬁcation of the microtubule network formation was performed by automated analysis of microscopy
images using Imaris software. Values are means ± SEM. n.s., not signiﬁcant; ***p < 0.001; n= 5. d Confocal microscopy. Human blood neutrophils from
control individuals pretreated with the indicated inhibitors were stimulated with GM-CSF/C5a. Extracellular DNA was stained with MitoSOX™ Red and the
nucleus with Hoechst 33342 (blue). Bars, 10 μm. Right: quantiﬁcation of the released dsDNA in supernatants of activated neutrophils. Values are means ±
SEM. n.s., not signiﬁcant; ***p < 0.001; n= 3
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microtubule network (Fig. 4a) and to release extracellular
DNA following activation (Fig. 4b). Quantiﬁcation of dsDNA
in neutrophil supernatants conﬁrmed the DNA release by
Opa1NΔ neutrophils in the presence of exogenous ATP or
NMN (Fig. 4b, right panel). Similar results for DNA release
were obtained following stimulation of neutrophils with
PMA, P. aeruginosa or immune complexes (Supplementary
Fig. 7a, b).
It should be noted that addition of exogenous ATP alone did
not trigger DNA release either in human (Supplementary Fig. 8a)
or in mouse neutrophils (Supplementary Fig. 8b), largely
excluding the possibility that Opa1NΔ neutrophils release DNA
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Fig. 3 Lack of Opa1 alters mitochondrial morphology and cristae structure. a Transmission electron microscopy (TEM). Primary mature neutrophils from
Opa1NΔ and control mice were ﬁxed and analyzed. Representative images are shown. Bars, 5 µm. Insets to the sides, bars, 1 µm. Mitochondria were further
analyzed at higher magniﬁcation and statistical analyses are provided below in (b), (e), and (f). b The average numbers of mitochondria per neutrophil was
quantiﬁed in at least 100 cells. Values are means ± SEM (n= 3); n.s., not signiﬁcant. c Quantitative PCR. Freshly puriﬁed mature neutrophils from Opa1NΔ
and control mice were analyzed for the number of DNA copies of mitochondrial mouse cytochrome c oxidase subunit 1 (mt-Co1) relative to mouse β2
microglobulin (B2M) which was used as a single copy nuclear-encoded reference gene. Values are means ± SEM (n= 3); n.s., not signiﬁcant. d Confocal
microscopy. Primary mature mouse neutrophils from Opa1NΔ and control mice were stained for TFAM expression (green) and DNA (red) using anti-TFAM
antibody and PI. Bars, 10 µm; n= 3. e Average mitochondrial major axis length in freshly puriﬁed mature neutrophils from Opa1NΔ and control mice. Images
were acquired by TEM and subsequently analyzed using the measurement points module of Imaris software. Data were collected from at least ﬁve
mitochondria per cell and more than 50 neutrophils per experiment. Values are means ± SEM. ***p < 0.001; n= 3. fMorphometric analysis of cristae width
in 60 randomly selected mitochondria of freshly puriﬁed mature neutrophils from Opa1NΔ and control mice. Values are lengths in arbitrary units (AU) and
shown as means ± SEM. ***p < 0.001; n= 3. g Total cellular ATP production by freshly puriﬁed mature neutrophils from Opa1NΔ and control mice was
measured by ATP-dependent luciferase activity using an ATP determination kit. Relative luciferase units (RLU) are shown as means ± SEM. **p < 0.01; n=
5. Quantiﬁcation of the data obtained in activated neutrophils is provided in Supplementary Fig. 6
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as a consequence of P2X receptor activation. Moreover, the
addition of exogenous ATP had no effect on the viability of either
human (Supplementary Fig. 8c) or mouse neutrophils (Supple-
mentary Fig. 8d). We also obtained no evidence for increased
apoptosis of Opa1NΔ compared to Lyz2Cre/Cre neutrophils
(Supplementary Fig. 8d); a pan-caspase inhibitor failed to restore
DNA release in GM-CSF/C5a-activated Opa1NΔ neutrophils
(Supplementary Fig. 8e), suggesting that, as an explanation for
the inability of Opa1NΔ neutrophils to form NETs, a difference in
apoptosis regulation can be excluded.
In order to determine the source(s) for ATP production in
human and mouse neutrophils, we applied speciﬁc inhibitors
blocking different steps of mitochondrial respiration and
glycolysis and measured total cellular ATP concentrations. After
70 min treatment of human neutrophils with the mitochondrial
ATP synthase inhibitor oligomycin A or with the glycolysis
inhibitor 2-deoxy-D-glucose (2-DG), we observed that inhibition
of glycolysis clearly reduced ATP production, whereas inhibition
of mitochondrial ATP synthase had no effect on neutrophil ATP
levels (Fig. 5a). Moreover, we analyzed the ATP/ADP ratio as a
measure for the energetic state of the cell and observed that the
ratio was reduced by 2-DG in control Lyz2Cre/Cre mouse
neutrophils, but the reduced levels already attained in Opa1NΔ
neutrophils were not further reduced (Fig. 5b). Following GM-
CSF/C5a stimulation, control neutrophils exhibit a reduced ATP/
ADP ratio as a consequence of reduced ATP production, perhaps
owing to the energy requirement for microtubule network
rearrangements as previously suggested37. The fact that the fall
in ATP concentration following neutrophil activation is not
balanced by any measurable increase in ADP or AMP
concentration has been reported previously38. Our data support
the concept that glycolysis is the main source of ATP production
in neutrophils18 and indicate that Opa1NΔ neutrophils exhibit a
defect in glycolysis.
Despite the fact that glycolysis in the cytoplasm is the main
source of ATP production in neutrophils, surprisingly, the
mitochondrial complex I inhibitor rotenone also reduced ATP
levels (Fig. 5a), indicating a link between glycolysis and the
mitochondrial complex I pathway for ATP production in
neutrophils. To examine whether Opa1 depletion has any effect
on complex I activity in neutrophils, we analyzed the enzymatic
activities of the mitochondrial complex I (CI) and complex III
(CIII) normalized to citrate synthase (CS). The results clearly
show that both resting and activated Opa1NΔ neutrophils exhibit
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a signiﬁcant defect in CI, but not CIII, activity (Fig. 5c), and in a
diminished NAD+/NADH ratio (Fig. 5d). In the process of
glycolysis, glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
requires two NAD+ molecules per glucose molecule. Therefore,
NAD+ availability is an important determinant for the rate of
glycolysis39,40. Consistent with reduced glycolysis, we have also
found reduced lactate levels in Opa1NΔ as compared to Lyz2Cre/
Cre neutrophils (Fig. 5e).
To better understand the basal level of glycolytic function in
Opa1NΔ and control Lyz2Cre/Cre mouse neutrophils, the extra-
cellular acidiﬁcation rate (ECAR; an indicator of aerobic glycolysis)
and oxygen consumption rate (OCR; an indicator of OXPHOS)
were analyzed. Consistent with the lactate ﬁndings (Fig. 5e), we
found a general decrease in basal ECAR in Opa1NΔ compared to
control Lyz2Cre/Cre mouse neutrophils (Supplementary Fig. 9a, left
panel). A lower ECAR in Opa1NΔ neutrophils was also seen after
blocking CI or CV activities or adding the mitochondrial
uncoupling agent p-triﬂouromethoxyphenylhydrazone (FCCP)
(Supplementary Fig. 9a, right panel). Inhibition of CI activity had
no effect in Opa1NΔ neutrophils (Supplementary Fig. 9a, left panel),
in agreement with the observation that these cells already exhibit a
defect in CI activity (Fig. 5c). The addition of 2-DG abolished
extracellular acidiﬁcation in both Opa1NΔ and control Lyz2Cre/Cre
neutrophils (Supplementary Fig. 9a, left and right panels),
conﬁrming that neutrophils entirely depend on glycolysis. In
agreement with this concept, both Opa1NΔ and control Lyz2Cre/Cre
neutrophils exhibit very low OCR (Supplementary Fig. 9b, left
panel). The limited OCR in neutrophils is even further reduced in
Opa1NΔ neutrophils which, however, is an observation that gains
statistical signiﬁcance only at maximal respiration after adding
FCCP (Supplementary Fig. 9b, right panel). The discrepancies
between the clearly reduced CI activity and the only mildly affected
OCR might be explained by the fact that mitochondria of
neutrophils can receive electrons from glycolysis via glycerol-3-
phosphate through the glycerophosphate dehydrogenase complex
in the Q cycle41. Taken together, our data suggest that a lack of
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OPA1 impairs complex I activity, reducing available NAD+ levels,
and hence the rate of glycolysis, resulting in reduced ATP
production.
Since we observed a defect in the formation of microtubules
and NETs following activation of OPA1-deﬁcient human and
mouse neutrophils, we investigated whether a pharmacological
block in glycolysis and mitochondrial CI activity would also
interdict the microtubule network assembly, thus resulting in
inhibition of DNA release. Indeed, we found that blocking
glycolysis (2-DG) or CI (rotenone or piericidin A), but not CIII
(antimycin A) or ATP synthase (oligomycin A), resulted in an
inability of normal mouse (Fig. 6a) and human neutrophils
(Supplementary Fig. 10) to form microtubule networks or to
release DNA upon combined activation with GM-CSF and C5a
(Fig. 6b). To prove that ATP is sufﬁcient to rescue the formation
of the microtubule network and DNA release, we added either
ATP or NMN to GM-CSF/C5a-activated control mouse
neutrophils pre-treated with rotenone, piericidin A or 2-DG.
Indeed, both exogenous ATP and NMN resulted in successful
activation of neutrophils in spite of pharmacological block on
CI activity or overall glycolysis (Fig. 6a, b; lower panels).
These data support the concept that microtubule network
assembly and DNA release depend on ATP generated by
glycolysis, for which an OPA1-dependent mitochondrial complex
I activity is required.
To demonstrate the importance of OPA1 for functional NET
formation, we performed bacterial killing assays in vitro. We
observed reduced bacterial killing of P. aeruginosa and
E. coli–GFP by Opa1NΔ as compared to Lyz2Cre/Cre neutrophils
(Fig. 7a). Moreover, addition of DNase I lowered bacterial killing
by Lyz2Cre/Cre neutrophils to levels similar to Opa1NΔ neutrophils.
Conversely, DNase I had no effect on Opa1NΔ neutrophils,
indicating that the lack of DNA release constitutes the principal
cause of the reduced antibacterial activity of Opa1NΔ neutrophils
(Fig. 7a). To investigate the importance of mitochondrial complex
I and complex III activities, we pre-treated Lyz2Cre/Cre neutrophils
with rotenone and antimycin A. Rotenone, but not antimycin A,
reduced the neutrophil killing activity, demonstrating the
importance of complex I activity for functional NET formation.
In contrast, rotenone had no effect on Opa1NΔ neutrophils
(Fig. 7a). Importantly, exogenous ATP or NMN rescued the
defective bacterial killing activity of Opa1NΔ neutrophils (Fig. 7a).
To exclude the possibility that a failure of P. aeruginosa and E.
coli–GFP killing by Opa1NΔ neutrophils might be due to a lack of
phagocytic activity, we performed phagocytosis assays using
opsonized E. coli-GFP. Equal phagocytic activities were observed
in Opa1NΔ and Lyz2Cre/Cre neutrophils (Fig. 7b), suggesting that
phagocytosis is largely independent of OPA1.
Opa1NΔmice exhibit a reduced antibacterial defense capability.
NETs can bind and kill bacteria and fungi in the extracellular
space1,21. To deﬁne the physiological importance of OPA1 in
shaping the outcome of a bacterial lung infection, mice were
intranasally inoculated with P. aeruginosa42. After 18 h, the
median bacterial counts in the lungs of Opa1NΔ mice were higher
than for Lyz2Cre/Cre control mice (Fig. 7c). Moreover, systemic
infection was more frequently observed in Opa1NΔ mice, as
shown by signiﬁcantly higher median CFU counts in the spleen
(Fig. 7d).
Neutrophil recruitment is a pivotal event of the response to P.
aeruginosa infection42,43. To quantify neutrophil inﬁltration, lung
homogenates were assessed for the neutrophil-speciﬁc enzyme
myeloperoxidase activity (MPO). After 18 h infection, MPO
enzymatic activity levels in lung homogenates of Opa1NΔ mice
were higher than in Lyz2Cre/Cre control mice, suggesting that
there is no defect in the neutrophil recruitment to the lungs of
Opa1NΔ mice (Fig. 7e).
To analyze the formation of NETs, lung tissues were
investigated following staining of DNA and MPO. As expected,
following infection, lung sections revealed the presence of NETs
in Lyz2Cre/Cre control mice. In contrast, NET formation in
Opa1NΔ mice was largely abolished (Fig. 7f). Counting the
numbers of inﬁltrating neutrophils revealed again evidence for
increased neutrophil inﬁltration in the lungs in Opa1NΔ
compared to control mice (3917 ± 963 versus 1742 ± 319
neutrophils per mm2; p < 0.05). We additionally performed an
automated analysis to quantify neutrophil numbers, conﬁrming
increased neutrophil inﬁltration in Opa1NΔ compared to Lyz2Cre/
Cre control mice (Fig. 7f, second right panel). Taken together,
despite increased neutrophil recruitment to the site of infection
and normal phagocytic activity, Opa1NΔ mice fail to resolve
bacterial lung infections, consistent with the lack of NET
formation.
Discussion
Neutrophils are rapidly recruited in tissues during infections to
eliminate pathogens44, not only by phagocytosis, but also in the
extracellular space by the formation of NETs1. Currently, there is
a dispute in the literature regarding the source of extracellular
DNA employed for the formation of NETs and whether there is a
requirement for neutrophil death in NET formation45. Conse-
quently, the molecular mechanism of NET formation remains
unclear. Another matter of contradiction is the question of the
functional signiﬁcance of mitochondria in neutrophils. Since
mitochondrial respiration is low in these cells, it has been sug-
gested that neutrophils require mitochondria just for undergoing
apoptosis18. On the other hand, it has been demonstrated that
neutrophils possess a highly developed mitochondrial network
that is important during infection and inﬂammation46,47. Here,
we complement this body of evidence, extending a role of
mitochondria in NET formation. Speciﬁcally, we report that
mitochondrial complex I activity indirectly regulates glycolysis,
which is required for microtubule network assembly and func-
tional NET formation both in vitro and in vivo.
Recently, several researchers report release of mtDNA during
NET formation, supporting our earlier ﬁndings2. For instance,
mtDNA release by neutrophils has been intensely studied in
systemic lupus erythematous (SLE) patients48. In this auto-
immune disease, mtDNA acts as the most potent activator of
plasmacytoid dendritic cells (pDCs) and the type I interferon
(IFN) pathway49. Moreover, following activation of neutrophils
with ribonucleoprotein immune complexes (RNP ICs), mito-
chondria were shown to be mobilized toward the cell surface
where they released oxidized mtDNA in a mitochondrial ROS-
dependent manner29. Additionally, a direct fusion of mitochon-
drial membranes with the plasmalemma as a potential mtDNA
release mechanism in neutrophils has been postulated50. How-
ever, no conclusive molecular mechanism of mtDNA release has
yet been reported.
To investigate the role of mitochondrial dynamics in NET for-
mation, we have used super-resolution, confocal and TEM micro-
scopy to analyze the interconnected tubular mitochondrial network
in healthy human and mouse neutrophils. Down-regulation of
different genes known to be responsible for mitochondrial fusion
and ﬁssion using shRNA has pointed to an important role for
OPA1 in facilitating DNA release. OPA1 is important for mito-
chondrial biogenesis and fusion35. Moreover, OPA1 regulates the
shape of the mitochondrial cristae and their “tightness”, a function
needed for maintaining ion gradients, hence for overall respiratory
efﬁciency35. Human and mouse neutrophils devoid of functional
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OPA1 protein display not only a fragmented mitochondrial mor-
phology, but also lack microtubule networks which are required for
mitochondrial translocation, the process of degranulation, and the
ability to form functional NETs upon activation. It should be noted
that OPA1 cleavage in cerebellar granule neurons (CGNs) coincides
with extensive mitochondrial fragmentation and disruption of the
microtubule network31. While we could pharmacologically
demonstrate a requirement for the microtubule network for NET
formation, we do not formally demonstrate why this is the case.
However, disorientation of mitochondria in cells exhibiting a
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disrupted microtubule array could explain the lack of extracellular
DNA release by ADOA and Opa1NΔ neutrophils.
Microtubule polymerization is an energy-dependent process37.
It has been demonstrated that ATP is able to polymerize
microtubules through an interaction at the exchangeable GTP
site51 and that reducing ATP synthesis leads to decreased
microtubule stability52. We demonstrate that low levels of cellular
ATP in OPA1-deﬁcient neutrophils are insufﬁcient for micro-
tubule network and NET formation, a situation that could be
reversed by addition of exogenous ATP or NMN which rescued
NAD+ levels. Surprisingly, however, actin polymerization and
phagocytosis did not appear to be inﬂuenced by the lack of OPA1,
suggesting that these events require less ATP. But why should
OPA1, a mitochondrial protein known to be involved in mito-
chondrial ATP production, be important in neutrophils, which
depend on glycolysis for ATP? Using neutrophils deﬁcient in
Opa1, we observed that a lack of OPA1 caused remodeling of
mitochondrial cristae structure, resulting in reduced mitochon-
drial complex I activity and lower levels of NAD+, which is a key
participant in glycolysis40. Therefore, diminution of glycolysis as
the main ATP production pathway in neutrophils is the reason
for low cellular ATP levels in ADOA and Opa1NΔ neutrophils,
explaining their inability to form microtubule networks and
functional NETs. These ﬁndings were conﬁrmed with a phar-
macological approach using inhibitors of mitochondrial complex
I activity and glycolysis.
We also provide data showing that OPA1 function is important
for anti-microbial defense by neutrophils in an in vivo model of
P. aeruginosa lung infection. Mice lacking Opa1 in their neu-
trophils and macrophages did not form NETs and were less able
to eliminate bacteria from the lungs. Moreover, these mice
exhibited a greater probability of systemic spread of infection.
Therefore, pharmacological activation of OPA1 in neutrophils
might be a new option for ﬁghting bacterial and fungal infections.
Moreover, clinicians should be aware of the possibility that
ADOA patients may exhibit an increased risk of infections. Taken
together, the ﬁndings in this study provide further evidence for a
role of mitochondria in the biology of neutrophils, particularly for
NET formation, and extend the impact of an OPA1 function to
the innate immune response.
Methods
Reagents. Granulocyte/macrophage colony-stimulating factor (GM-CSF) was
provided by Novartis Pharma (Nürnberg, Germany). Human and mouse C5a were
purchased from Hycult Biotech (Uden, the Netherlands). MitoSOX Red, Alexa
Fluor 488 Phalloidin, MitoTracker Orange CM-H2TMRos, SYTO13, propidium
iodide, CellMask Deep Red, Prolong Gold mounting media, Hoechst 33342, the
Quant-iTTMPicoGreen®dsDNA Assay Kit and RPMI 1640/GlutaMAX medium
were obtained from ThermoFisher Scientiﬁc (distributed by LuBioScience GmbH,
Lucerne, Switzerland). X-VIVO 15 medium was from Lonza (Walkersville, MD,
USA). Polyvalent human IgG was a kind gift from CSL Behring (Bern, Switzer-
land). Normal goat (Cat # NBP2-23475, dilution 1:400), rat (Cat # NBP2-33356,
dilution 1:400), and rabbit (Cat # NBP1-71681, dilution 1:400) sera were purchased
from Novus Biologicals, Abingdon, UK. ChromPure human IgG (Cat # 009-000-
003, dilution 1:1000) and normal mouse sera (Cat # 015-000-120, dilution 1:400)
were obtained from Milan Analytica AG (Rheinfelden, Switzerland). Bovine serum
albumin (BSA), glutaraldehyde, saponin, sodium borohydride (NaBH4), ATP,
lipopolysaccharide (LPS, 055:B5), dihydrorhodamine 123 (DHR), 10% formalin
solution, β-nicotinamide adenine dinucleotide (NADH), β-nicotinamide mono-
nucleotide (NMN), piericidin A (PA), potassium cyanide (KCN), rotenone (Rot),
antimycin A (Anti A), oligomycin A (Oli A), 2-deoxy-D-glucose (2-DG), noco-
dazole, taxol, propidium iodide, cytochalasin B, tris base, ubiquinone1, bovine
serum albumin (fatty acid free), sodium dodecyl sulfate (SDS), protease inhibitor
cocktail, tryptic soy broth, and agar, Luria broth base (LB), o-dianisidine dihy-
drochloride, Triton X-100, N,N-dimethylformamide (DMF), and Nutridoma-SP
were obtained from Sigma-Aldrich (Buchs, Switzerland). The NucleoSpin tissue kit
for genomic DNA extraction was purchased from Macherey Nagel AG (Oensingen,
Switzerland). IQ SYBR Green Supermix was from Bio-Rad Laboratories AG
(Cressier, Switzerland). The Mitochondria Isolation Kit and Pierce BCA protein
assay kit were from ThermoFisher Scientiﬁc as distributed by LuBioScience GmbH
(Luzern, Switzerland). The CellTiter-GloR luminescent assay, ADP/ATP-Glo™
bioluminescent assay, and NAD/NADH-Glo™ bioluminescent assay for detecting
total oxidized and reduced nicotinamide adenine dinucleotides as well as the
Lactate-Glo™ bioluminescent assay were from Promega AG (Dübendorf, Switzer-
land). Deoxyribonuclease (DNase I) was from Worthington Biochemical Cor-
poration (Lakewood, NJ, USA). Heparinized disposable glass pipettes were
supplied by (Provet AG, Lyssach, Switzerland). The Mouse Neutrophil Enrichment
Kit was from Stemcell Technologies (Grenoble, France). Pancoll-Human was
purchased from PAN-Biotech GmbH (Aidenbach, Germany). 12-mm high-quality
glass-cover slips for confocal microscopy analysis (Cat. # 1001/12) were purchased
from Karl Hecht “Assistent” GmbH (Sondheim/Rhön, Germany).
Opa1NΔ mice. We crossed mice bearing an Opa1ﬂox allele, in which, following Cre-
mediated recombination, the deletion of Opa1 exons 2 and 3 resulted in an
aberrant exon1-exon4 transcript35, with knock-in mice expressing Cre recombi-
nase under the control of the lysozyme 2 endogenous promoter (Lyz2Cre/Cre mice).
Lysozyme 2 is a marker of myeloid cells predominantly active in mature neu-
trophils and macrophages, and appears during late myeloid differentiation. The
resulting Opa1ﬂox/ﬂox_Lyz2Cre/Cre mice were designated Opa1NΔ mice. Lyz2Cre/Cre
mice or sometimes, additionally, Opa1ﬂox/ﬂox mice were used as controls in all
experiments. Mouse genomic DNA was tested by PCR to verify the genotypes and
homozygosity of Opa1ﬂox/ﬂox and Lyz2Cre/Cre alleles in Opa1NΔ mice. All mouse
experiments were approved by the Cantonal Veterinary Ofﬁce of Bern, Switzerland
(permission # BE5/15).
Genomic PCR for mice deﬁcient in Opa1. For genotyping of mice, genomic DNA
was extracted from an ear punch of mice using the NucleoSpin® Tissue Kit. PCR
ampliﬁcation was performed with 25 ng of total DNA using the following mouse
primers (Opa1 forward: 5′-CAG TGT TGA TGA CAG CTC AG-3′; and reverse:
5′- CAT CAC ACA CTA GCT TAC ATT TGC-3′) and (Lyz2 forward: 5′-CCC
AGA AAT GCC AGA TTA CG-3′, 5′-CTT GGG CTG CCA GAA TTT CTC-3′,
and reverse: 5′-TTA CAG TCG GCC AGG CTG AC-3′), with SYBR Green
Supermix. The samples were placed on a PCR thermo cycler ampliﬁed at 94 °C for
5 min, annealing at the required temperature for each primer for 30 s and 60 °C for
30 s with an extension at 72 °C for 1 min, for 40 cycles. The PCR-ampliﬁed pro-
ducts were separated on 2% polyacrylamide gels.
cDNA analysis for exon 11 skipping in ADOA patients’ neutrophils. For OPA1
(NM_015560.2) exon 11 skipping, the following primer sequences were used: 3′-
GTG CTG GAA AGA CTA GTG TGT TG -5′ and 3′-AGT ATG ATG GCA TTA
GGA TTC TG-5′. Primers were synthesized by Microsynth AG (Balgach, Swit-
zerland). Total RNA was extracted using the QIAGEN RNAeasy Kit. cDNA
synthesis was performed using random hexamers with Invitrogen SuperScript II.
The samples were placed on a PCR thermo cycler, ampliﬁed at 94 °C for 5 min,
annealing at required temperature for each primer for 30 s and 60 °C for 30 s with
an extension of 72 °C for 1 min, for 40 cycles. The PCR-ampliﬁed products were
separated on 1.5% agarose gels.
Isolation of mouse bone marrow and human blood neutrophils. All mice were
analyzed between 8 and 13 weeks of age. Blood was collected from the retro-orbital
sinus of sedated mice, using heparinized disposable glass pipettes. Total leukocyte
cell counts in blood were measured on a Scil Vet ABC Hematology Analyzer
(Horiba Medical, Montpellier, France). For serum preparation, the blood was left to
clot for 2 h at room temperature and centrifuged (20 min, 960 × g, 4 °C). Bone
marrow cells were collected by ﬂushing the femur with 5 ml of 2% FCS in PBS,
using a 26-gauge needle, and ﬁltering through a sterile 70-μm mesh nylon cell
strainer. Bone marrow single-cell suspensions were then washed with medium and
the cells counted with a hemocytometer, using the Türk’s staining solution (Dr.
Grogg Chemie AG, Stettlen, Switzerland). Primary bone marrow neutrophils were
isolated by the negative selection technique, using an EasySep mouse neutrophil
enrichment kit. Neutrophil purity was always higher than 90% as assessed by
staining with the Hematocolor Set (Merck Millipore) followed by light microscopy
analysis. Human neutrophils were isolated from healthy individuals and ADOA
patients’ blood21. Brieﬂy, cell separation was performed by Ficoll-Hypaque cen-
trifugation (Pancoll human from PANTM BioTech). The granulocyte fraction was
depleted of erythrocytes by lysis with a buffer containing NH4Cl, KHCO3 and
EDTA. The resulting cell populations contained >95% neutrophils as assessed by
Diff-Quik staining and light microscopy. Written, informed consent was obtained
from all blood donors, and the Ethics Committee of the Canton Bern approved the
study.
Neutrophil activation. Human and mouse neutrophils were seeded on 12-mm
glass cover slips in X-VIVOTM 15 medium (Lonza, Walkersville, MD, USA),
primed with 25 ng per ml GM-CSF for 20 min, and subsequently stimulated with
10−8 M C5a, 100 ng per ml LPS or co-cultured with Escherichia (E.) coli GFP M655
(E. coli-GFP; a kind gift of E. Slack, ETH Zurich) for 15 min. In selected experi-
ments, the following inhibitors were used 30 min before GM-CSF priming: Oli-
gomycin A (2.5, 5, or 10 µg per ml), 2-DG (1, 3, 5 mM), rotenone (10 µM),
antimycin A (5 µg per ml), Q-VD (20 µM), taxol (1 µM) and nocodazole (5 µM). In
other experiments, cells were pre-cultured for 30 min in the presence of ATP (10,
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100 µM, or 1 mM) or NMN (500 μM) and then stimulated for 45 min, besides GM-
CSF/C5a, also with RNP-ICs-SLE [IgG, puriﬁed from with SLE antibody positive
human plasma (Cat # DA1805, Trina Bioreactive AG, Nänikon, Switzerland,
dilution 1:33), mixed with small nuclear ribonucleoprotein (SmRNP) (Cat #
ATR01-02, Arotec, New Zealand, dilution 1:100)] or RNP-ICs-Ab [an anti-
damaged DNA/RNA monoclonal antibody (clone 15A3, Cat # SMC-155, Stress-
Marq Biosciences, Victoria, Canada, dilution 1:33) mixed with SmRNP]29 or
P. aeruginosa (ATCC-BAA-47; strain HER-1018)42; with a multiplicity of infection
of 10:1 (bacteria to neutrophils).
PLB-985 cells. The human myeloid leukemia cell line PLB-985 originally from
Collection of Microorganisms and Cell Cultures (DSMZ, Germany Cat # ACC
139), and was kindly provided by V. Witko-Sarsat, Cochin Institute, Paris, France,
was cultured in RPMI 1640+ GlutaMAX medium supplemented with 10% FCS, 50
units per ml penicillin and 50 µg per ml streptomycin. Cell cultures were passaged
twice or three times a week to maintain a cell density between 2 × 105 and 1 × 106
per ml. For granulocytic differentiation, PLB-985 cells were cultured at a density of
2 × 105 per ml in RPMI 1640 medium supplemented with 0.5% N,N-dimethyl-
formamide (DMF), 1% Nutridoma-SP and 0.5% FCS53. The medium was changed
once on day 3 during the differentiation period. On day 6, the cells were cen-
trifuged and resuspended in fresh medium.
Down-regulation of mitochondria-shaping proteins by shRNA. Human and
mouse short hairpin RNAs (shRNA) were subcloned in HIV-derived lentivirus
vector pLKO.1-puromycin (human cells) or G418 (mouse cells) with a U6 pro-
moter that had been purchased from Sigma-Aldrich. Lentiviral vector containing
shRNA were calcium phosphate transfected together with a lentivirus envelope
protein vector pMD2G and the packaging vector psPAX2 (provided by D. Trono,
École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland) into 293T/17
cells from American Type Culture Collection (ATCC, USA Cat # CRL-11268).
Supernatants were collected after 24 and 48 h, cleared by low-speed centrifugation
(425 × g for 10 min), ﬁltered through a 0.22-μm ﬁlter (Merck Millipore), and the
lentivirus vectors encoding human and mouse shRNAs added to human myeloid
leukemia cell line (PLB-985) and mouse Hoxb8 cell lines20, respectively.
pLKO.1 constructs encoding shRNAs against human and mouse were obtained
from Sigma-Aldrich (Mission shRNA).
shRNA primer sequences: DRP1 (TRCN0000001097, CCG GGC TAC TTT
ACT CCA ACT TAT TCT CGA GAA TAA GTT GGA GTA AAG TAG CTT
TTT), mouse Drp1 (TRCN0000012605, CCG GGC TTC AGA TCA GAG AAC
TTA TCT CGA GAT AAG TTC TCT GAT CTG AAG CTT TTT), human FIS1
(TRCN0000155375, CCG GCA AGA GCA CGC AGT TTG AGT ACT CGA GTA
CTC AAA CTG CGT GCT CTT GTT TTT TG), mouse Fis1 (TRCN0000124386,
CCG GCC TGG TTC GAA GCA AAT ACA ACT CGA GTT GTA TTT GCT TCG
AAC CAG GTT TTT G), humanMFN1 (TRCN0000051833, CCG GGC TCC CAT
TAT GAT TCC AAT ACT CGA GTA TTG GAA TCA TAA TGG GAG CTT TTT
G), mouse Mfn1 (TRCN0000081401, CCG GGC GTT TAA GCA GCA GTT TGT
ACT CGA GTA CAA ACT GCT GCT TAA ACG CTT TTT G), human OPA1
(TRCN0000082846, CCG GCC GGA CCT TAG TGA ATA TAA ACT CGA GTT
TAT ATT CAC TAA GGT CCG GTT TTT G), or mouse Opa1
(TRCN0000091111, CCG GCC GAC ACA AAG GAA ACT ATT TCT CGA GAA
ATA GTT TCC TTT GTG TCG GTT TTT G).
The down-regulation of DRP1, FIS1, MFN1, and OPA1 after antibiotic selection
was controlled by qPCR using primers as follows: human DRP1 (forward: 5′- TTC
AAT CCG TGA TGA GTA TGC-3′, reverse 5′-TTA GAA GAG ACT GAT ACT
GAG CA-3′), mouse Drp1 (forward: 5′-GAG TGT AAC TGA TTC AAT-3′,
reverse 5′-GCA TAA GTA ACC TAT TCA-3′), human FIS1 (forward: 5′-AAG
AGC ACG CAG TTT GAG-3′, reverse 5′-CAG GTA GAA GAC GTA ATC CC-
3′), mouse Fis1 (forward: 5′-AGC GGG ACT ATG TCT TCT-3′, reverse 5′-GCA
CAT ACT TTA GAG CCT TT-3′), human MFN1 (forward: 5′-GTT GGA GCG
GAG ACT TAG-3′, reverse 5′-CGG ATT CTT ATA TGT TGC TTC AA-3′),
mouse Mfn1 (forward: 5′-TAA TGG CAG AAA CGG TAT-3′, reverse 5′-TTC
CTG TAT GTT GCT TCA-3′), or human OPA1 (forward: 5′-GGT TGT TGT GGT
TGG AGA T-3′, reverse 5′-AGA GTC ACC TTA ACT GGA GAA-3′), mouse
Opa1 (forward: 5′-AAG TGA CAA GCA TTA CAG G-3′, reverse 5′-CTC CAA
GAT CCT CTG ATA CT-3′).
Reactive oxygen species measurements. ROS measurements in human and
mouse neutrophils were performed using ﬂuorescent detection of ROS activity by
ﬂow cytometer21. Neutrophils (2 × 106 per ml) were resuspended in X-VIVOTM 15
medium and neutrophils primed with GM-CSF and subsequently stimulated with
C5a. For positive control experiments, we stimulated neutrophils with PMA
(25 nM) in the absence of GM-CSF priming. DHR 123 was added to the cells at the
ﬁnal concentration of 1 μM. The reaction was stopped by adding 200 μl of ice-cold
PBS, and the ROS activity of the samples was immediately measured by ﬂow
cytometry (BD FACSCalibur) and quantiﬁed using FlowJo software (Tree Star,
Ashland, OR, USA).
NET formation. Neutrophils were ﬁxed with 4% paraformaldehyde for 10 min,
washed with PBS, pH 7.4, and permeabilized using 0.05% saponin in PBS pH 7.4
for 2.5 min at room temperature. Subsequently, staining was performed in the
presence of 0.05% saponin. Nonspeciﬁc binding was reduced by pre-incubation of
the adherent cells with a blocking buffer (containing human immunoglobulins) at
room temperature for 20 min. Indirect immunoﬂuorescence staining was per-
formed, using polyclonal goat anti-mouse neutrophil elastase (M-18, Cat # SC-
9518, Santa Cruz Biotechnology, dilution 1:50) or polyclonal goat anti-mouse MPO
(E-15, Cat # SC-34159, Santa Cruz Biotechnology, dilution 1:50) and rabbit anti-
TFAM (Cat # NBP1-67995, Novus Biologicals, dilution 1:100) primary antibodies,
diluted in blocking solution, and incubated overnight at 4 °C for staining tissue
sections or 2 h for isolated neutrophils21. As staining controls, either mouse or
rabbit control antibodies at the corresponding concentrations were employed.
Appropriate Alexa Fluor® 488 (Cat # A11055, ThermoFischer Scientiﬁc, dilution
1:400) or Cyanine Cy™3 (Cat # 715-167-003, Jackson ImmunoResearch, dilution
1:100)-conjugated secondary antibodies were incubated at room temperature for
1 h. DNA was stained with PI (10 μg per ml) or monoclonal mouse anti-dsDNA
(clone AE-2, Cat # MAB1293, Merck Millipore, dilution 1:200). Staining with cell-
permeable ﬂuorescent dyes, such as MitoSox Red (5 μM) or MitoTracker Orange
(1 μM), was performed in live cells prior to ﬁxation according to the corresponding
manufacturers’ instructions. Samples were mounted in Prolong Gold mounting
medium, image acquisition was performed using the confocal laser scanning
microscope LSM 700 (Carl Zeiss Micro Imaging, Jena, Germany) with a ×63/1.40
oil DIC objective and analyzed with Imaris software (Bitplane AG, Zurich, Swit-
zerland) as previously reported7,21.
Super-resolution multicolor imaging. High-resolution imaging was performed
with a structured illumination microscope Elyra S.1 (Carl Zeiss) equipped with a
Plan-Apochromat ×63/1.4 NA objective and an iXon 885 EM-CCD camera (Andor
Technology), and was piloted with the ZEN Blue 2010 D software (Carl Zeiss).
Image reconstruction was carried out with the Zen software (Carl Zeiss).
Quantiﬁcation of released dsDNA in culture supernatants. Neutrophils (2 × 106
neutrophils per 500 μl of X-VIVO™ 15 medium) were stimulated as described
above. At the end of the incubation period, a low concentration of DNase I (2.5 U
per ml; Worthington Biochemical Corporation, Lakewood, NJ, USA) was added for
an additional 10 min. Reactions were stopped by addition of 2.5 mM EDTA, pH
8.0. Cells were centrifuged at 200 × g for 5 min. One hundred microliters super-
natant were then transferred to black, glass-bottom 96-well plates (Greiner Bio-
One GmbH) and the ﬂuorescent activity of PicoGreen dye bound to dsDNA was
excited at 502 nm. The ﬂuorescence emission intensity was measured at 523 nm
using a spectroﬂuorimeter (SpectraMax M2, Molecular Devices, Biberach an der
Riß, Germany), according to the instructions described in the Quant-
iTTMPicoGreen® assay kit21.
Microtubule formation. Neutrophils were seeded on glass coverslips and stimu-
lated as described above. Samples were ﬁxed in mixture of 4% formaldehyde, and
0.1% glutaraldehyde in PBS (pH 7.4), and permeabilized ﬁrst with 0.5% Triton X-
100 for 15 min, followed by a 15-min incubation with 0.5% sodium dodecyl sul-
phate (SDS) at room temperature. Autoﬂuorescence was then quenched with 0.5
mg per ml sodium borohydride (NaBH4) in PBS (pH 7.4) for 10 min on ice.
Nonspeciﬁc binding to the Fc-receptor was blocked with a blocking buffer [7.5%
BSA, 30% human IgG polyvalent (IVIG), and 30% normal goat sera (matching
species with secondary antibody) and 1% ChromPure human IgG in PBS] at room
temperature for 1 h. Anti-α-tubulin monoclonal antibody (clone DM1A, Cat #
T9026, Sigma-Aldrich, dilution 1:100,000) was diluted in blocking buffer and
incubated overnight at 4 °C, subsequently washed three times in PBS (pH 7.4) with
0.025% Triton X-100, and then further incubated with the secondary antibody,
Alexa-555 or -488 goat anti-mouse IgG (Cat # A32727 or A32723, ThermoFischer
Scientiﬁc, dilution 1:1000) diluted in 7.5% BSA plus 0.025% Triton X-100 at room
temperature for 1 h. Following extensive washing with PBS (pH 7.4) plus 0.025%
Triton X-100, the samples were counterstained with 1 μg per ml Hoechst 33342 at
room temperature for 5 min in the dark. After several washes, the samples were
mounted on glass slides using Prolong Gold mounting medium19,54. Images were
acquired using the LSM 700. Ten representative pictures from each condition,
containing more than 20 cells, were subjected to automated analysis to measure
ﬂuorescence mean intensity of anti-α-tubulin before and after the activation period
using automated isosurface module of Imaris software.
F-actin staining and quantiﬁcation. Neutrophils were seeded on 12-mm glass
cover slips and treated as described above. Staining with MitoTracker Orange
(1 μM), was performed in live cells prior to ﬁxation. Cells were ﬁxed with 4%
paraformaldehyde for 5 min, subsequently washed three times in PBS (pH 7.4), and
permeabilized with 0.5% saponin in buffer A (1% BSA in PBS) for 5 min at room
temperature. F-actin was stained using 1.25% solution (7 μM) of Alexa Fluor® 488
Phalloidin (green) in PBS (pH 7.4) plus 0.05% BSA and 0.5% of saponin for 15 min
at room temperature, protected from light. Cells were washed two times in PBS
(pH 7.4) and counterstained with 1 μg per ml Hoechst 33342 to visualize the nuclei.
After washing three times in PBS (pH 7.4), samples were mounted in Prolong Gold
mounting media. Slides were examined and images acquired by confocal laser
scanning microscopy (LSM 700). Ten representative pictures from each condition,
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containing more than 20 cells, were subjected to automated analysis to measure
ﬂuorescence mean intensity of F-actin before and after the activation period, using
the automated isosurface module of Imaris software.
Analysis of mitochondrial localization. Imaris software was employed for
quantiﬁcation of mitochondrial localization. MitoTracker-stained mitochondria
were imaged with an LSM 700 confocal microscope and processed using mea-
surement point module and tab Intensity tool within Imaris software to quanti-
tatively analyze images. Ten representative pictures from each condition,
containing more than 20 cells were used to determine the localization of mito-
chondria with respect to their distance from the plasma membrane55.
Immunoblotting. Cell lysates of primary bone marrow-derived mouse or human
blood neutrophils were prepared by lysing the cells with lysis buffer containing 50
mM Tris pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 2 mM EDTA, 10
mM sodium pyrophosphate, 50 mM sodium ﬂuoride, 200 μM Na3VO4 and 1mM
PMSF in H2O. Shortly before use, a protease inhibitor cocktail was added to the
lysis buffer. Cells were lysed for 25 min on ice, with frequent vortexing. After the
lysis, supernatants were collected following high-speed centrifugation (10 min,
17,949 × g, 4 °C). In all, 30–50 μg of protein was loaded on 12% SDS poly-
acrylamide gels (Expedeon, Lucerna-Chem). The samples were separated by elec-
trophoresis under reducing conditions and transferred onto polyvinylidene
diﬂuoride (PVDF) membranes (Immobilon-P; Merck Millipore). Membranes were
blocked with 5% non-fat dry milk in Tris-buffered saline solution containing 0.1%
Tween 20 (TBST) for 1 h, followed by incubation with monoclonal anti-OPA1
antibody (clone 18/OPA1, Cat # 612606, BD Biosciences, dilution 1:1000) in TBST
and 5% non-fat dry milk at 4 °C overnight. Membranes were washed using TBST,
then incubated with the corresponding HRP-conjugated secondary antibody (Cat #
GENA931, Sigma-Aldrich, dilution 1:10,000) and visualized by chemiluminescence
(ECL Western Blotting Analysis System; GE Healthcare or Luminata Forte; Merck
Millipore).
Phagocytosis assay. E. coli-GFP (25 × 106 per ml) were opsonized with 2% mouse
serum in 1× Hank’s Balanced Salt Solution (HBSS; LuBioScience GmbH) for
15 min (rotating end-over-end, 37 °C). Primary bone marrow-derived mouse
neutrophils (0.5 × 106) were resuspended in 200 μl of X-VIVOTM medium without
phenol red or antibiotics and 200 μl of opsonized bacteria was then added to the
cells. The cells were incubated with the bacteria for 35 min (rotating end-over-end,
37 °C). Phagocytosis was stopped by adding 400 μl of ice-cold PBS with 0.02%
EDTA to the cells. After one washing step with 400 μl of ice-cold PBS, the cells
were analyzed by ﬂow cytometer (BD FACSCalibur).
Bacterial killing assay. A single colony of E. coli-GFP was cultured in Luria broth
base (LB) medium (Sigma-Aldrich) or a colony of P. aeruginosa was cultured in
tryptic soy broth at 37 °C, shaking, overnight. The bacterial cultures were diluted
1:100 in LB medium, grown to mid-logarithmic growth phase (OD600= 0.7) and
centrifuged at 1000 × g for 5 min. Bacterial pellets were washed twice with 1×
Hank’s Balanced Salt Solution (HBSS; LuBioScience GmbH) and again gently
centrifuged at 100 × g for 5 min to remove any clumped bacteria. Bacteria were
opsonized with 10% mouse sera (heat-inactivated) in 1× HBSS, rotating end-over-
end at 37 °C for 20 min, and then used immediately. Activated neutrophils (1 × 107
per ml in RPMI 1640 plus 2% FCS in absence of antibiotics) were mixed with an
equal volume of opsonized bacteria (5 × 107 per ml) at 1:5 ratios, in the presence or
absence of 100 U per ml DNase I (Worthington Biochemical Corporation, Lake-
wood, NJ, USA). The co-cultures of cells and bacteria were rotated end-over-end at
37 °C for 30 min. At the end of the incubation period, an equal volume of ice-cold
1× HBSS was added to each tube to stop the reaction, and cells were pelleted by
gentle centrifugation (5 min, 100 × g, 4 °C) using a swing-out rotor. Supernatants
containing bacteria were collected, diluted 1:300, plated on agar, and grown
overnight before counting the colonies. The tubes containing bacteria alone were
treated the same way and used as controls21.
Inoculum preparation. For each experiment, P. aeruginosa inoculum was freshly
prepared from a frozen glycerol stock and grown overnight on tryptic soy agar
(TSA)56. The inoculum was washed in PBS, and the concentration was adjusted by
spectrophotometry. The actual CFU in the inoculum was determined each time by
plating serial dilutions on TSA. Mice were inoculated with 2 × 106 CFU per mouse.
In vivo lung infection. Groups of mice were sedated with 100 mg per kg ketamine
and 10 mg per kg xylazine and intranasally inoculated by applying 10 μl of
inoculum onto each nare. Mice were killed after 18 h for tissue harvest. The dis-
sected spleen and right lung were homogenized, serially diluted in 1% protease
peptone, and plated in duplicate on TSA. Aliquots of lung homogenates were
stored at −80 °C until further analysis. Left lungs were ﬁxed in formalin solution
and processed for immunoﬂuorescence staining. Lung sections were stained using
goat anti-mouse MPO antibody (E-15, Cat # SC-34159, Santa Cruz Biotechnology,
dilution 1:50) at 4 °C overnight, followed by conjugated Alexa Fluor 488 donkey
anti-goat IgG (Cat # A11055, ThermoFischer Scientiﬁc, dilution 1:100) at room
temperature for 1 h, and subsequently with 10 μg per ml PI for 10 min.
MPO activity assay. MPO activity was measured in triplicate using a spectro-
photometric assay in 50 mM potassium phosphate, pH 6, containing 0.167 mg per
ml o-dianisidine dihydrochloride and 0.0005% hydrogen peroxide.
Measurement of mitochondrial DNA copy number. Total genomic DNA was
extracted from primary mouse or human neutrophils with a NucleoSpin® tissue kit.
Quantitative PCR (qPCR) assays were performed using iQ SYBR Green Supermix
(Bio-Rad Laboratories). Mouse primers57 were as follows: Mouse cytochrome c
oxidase subunit 1 (mt-Co1) (forward: 5′-CCA GTG CTA GCC GCA GGC AT-3′,
reverse 5′- TCT GGG TGC CCA AAG AAT CAG AAC A-3′) and for nDNA
primers mouse β2 microglobulin (mB2M1) (forward: 5′- ATG GGA AGC CGA
ACA TAC TG-3′, reverse 5′-CAG TCT CAG TGG GGG TGA AT-3′). Human
primers25 were as follows: human D-Loop (forward: 5′-CAT CTG GTT CCT ACT
TCA GGG-3′, reverse 5′-CCG TGA GTG GTT AAT AGG GTG-3′) and human
ATP synthase protein 8 (MT-ATP8) (forward: 5′-ATG GCC CAC CAT AAT TAC
CC-3′, reverse 5′-CAT TTT GGT TCT CAG GGT TTG-3′), and human β2
microglobulin (B2M) (forward: 5′-TGC TGT CTC CAT GTT TGA TGT ATC T-
3′, reverse 5′-TCT CTG CTC CCC ACC TCT AAG T-3′). Primers were synthe-
sized by Microsynth AG. Duplicate real-time PCRs were performed in the iQ5
Multicolor Real-time PCR Detection System (Bio-Rad Laboratories), with 25 ng
extracted genomic DNA, and 200 nM of each primer in 25 µl ﬁnal PCR mix. The
cycling variables were 3 min at 95 °C followed by 40 cycles of 10 s at 95 °C and 30 s
at 55 °C.
Enzyme assays of mitochondrial respiratory chain complexes I and III. Mito-
chondria from differentiated Hoxb8 mouse neutrophils were prepared using the
Mitochondria Isolation Kit according to manufacturer’s protocol (Thermo Fisher
Scientiﬁc). Isolated mitochondria were resuspended in 10 mM ice-cold hypotonic
Tris buffer (pH 7.6) and stored at −80 °C. Before use, mitochondria were subjected
to three cycles of sonication to disrupt the mitochondrial membrane. The enzy-
matic activities of CI, CIII and citrate synthase were determined spectro-
photometrically as described58 in 10–20 μg extracted protein using 1 ml sample
cuvettes at 30 °C. CI activity was measured as the rotenone-sensitive NADH:
decylubiquinone oxidoreductase reaction and the decrease in absorbance of NADH
oxidation was read at 340 nm. CIII function was measured as the antimycin A-
sensitive decylubiquinol:cytochrome c reductase reaction and increasing reduction
of cytochrome c was read at 550 nm. Citrate synthase was measured as the rate of
production of coenzyme A from oxaloacetate by measuring the reduction of 5,5′-
dithiobis-2-nitrobenzoic acid at 412 nm. The values were normalized to the
amount of protein in each sample. Enzymatic CI and CIII activities were calculated
as ratios to the mitochondrial marker enzyme citrate synthase (mU per mU citrate
synthase).
Extracellular ﬂux analysis using Seahorse XF24. OCR and ECAR were inves-
tigated simultaneously using a Seahorse XF24 bioanalyzer (Agilent Technologies,
CA, USA). Primary mouse neutrophils were seeded in unbuffered culture medium
at 480,000 per well in polylysine-coated XF24-well assay plates. After the initial
assessment of basal OCR and ECAR rates, sequential exposures to modulators of
mitochondrial function were injected at optimized concentrations using a standard
mitochondrial stress test paradigm. First, mitochondrial phosphorylation was
inhibited by adding oligomycin (2 µM). Next, the mitochondrial electron transport
chain was stimulated maximally by the addition of the uncoupler carbonyl cyanide-
p-triﬂuoromethoxyphenylhydrazone (1.5 µM, FCCP). Finally, mitochondrial
respiration was inhibited at the level of complex I by addition of rotenone (1 µM),
and glycolysis inhibited by injection of 2-deoxy-D-glucose (50 mM, 2-DG). Steady-
states were calculated as the mean of three OCR measurement cycles. After each
experiment, OCR and ECAR data were normalized to corresponding cell numbers
in each well using protein determination.
ATP/ADP, NAD+/NADH, and lactate measurements. Resting and activated
mouse neutrophils (4 × 106 per ml) were treated with and without glycolysis (2-
DG) or CI (rotenone) inhibitors for 70 min at 37oC in DMEM medium (no glu-
cose, no glutamine, no phenol red (Cat # A14430-01, Thermo Fisher Scientiﬁc). 12
mM D-glucose was added for lactate and ATP/ADP measurements. For NAD
+/NADH quantitative analysis, cells were treated as described above, but cultured
in PBS. Upon activation, cells were placed on ice for lactate analysis or the reaction
was stopped by adding Krebs-Ringer bicarbonate buffer (Cat # K4002, Sigma-
Aldrich) and cell pellets were resuspended in Krebs-Ringer bicarbonate buffer with
1% TCA (for ATP/ADP) or cold PBS (for NAD+/NADH). The ATP/ADP ratio
was measured by Cellular ADP/ATP‐Glo™ Assay (Promega AG), according to the
instructions of the manufacturer. Lactate and the NAD+/NADH ratio were mea-
sured for luciferase activity by Lactate-Glo™ Assay or NAD/NADH‐Glo™ Assay
(Promega AG), according to the instructions of the manufacturer. Values were
normalized to the total protein content.
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Degranulation assay. Primary bone marrow-derived mouse neutrophils (4 × 106
cells per ml) were resuspended in X-VIVOTM 15 medium, primed with GM-CSF
and subsequently activated with C5a. For degranulation analysis of azurophil
granule protein, in the ﬁnal 5 min of GM-CSF priming, cytochalasin B (5 µM) was
added to the cell suspension. Degranulation of azurophil granules was determined
by measuring the increase in CD63 expression as a surrogate marker. Surface
expression of CD63 was performed using PE-conjugated rat anti-mouse CD63
monoclonal antibody (clone NVG-2; Cat # 564222, BD Biosciences, dilution 1:50)
and ﬂow cytometry (FACSVerse, BD Biosciences)59. CD63 expression was quan-
tiﬁed using FlowJo software (Tree Star, Ashland, OR, USA). For β-glucosaminidase
activity, the reaction was stopped by adding ice-cold HBSS-0.1% BSA and the
supernatants were collected following a centrifugation step (20 min, 425 × g, 4 °C).
Cell pellets were lysed with 0.12% Triton X-100 for 10 min at room temperature.
The substrate solution (5 mM p-nitrophenyl-2-acetamido-2-deoxy-α-D-glucopyr-
anoside in 25 mM sodium citrate, pH 4.5) was added to the cell lysate and
supernatant followed by incubation at 37 °C for 1 h. The reaction was stopped by
adding 52 mM glycine-NaOH, pH 10.5, and the absorbance measured at 410 nm
using a SpectraMax M2 plate reader (Bucher Biotech). The amount of β-
glucosaminidase released in supernatants of neutrophils was expressed as a per-
centage of the total β-glucosaminidase60.
Transmission electron microscopy. Neutrophils were centrifuged at 425 × g and
4oC for 20 min. The supernatants were removed and 1 ml cold 2.5% glutaraldehyde
solution in 0.15 M HEPES was added to cell pellets. Electron microscopy images
were taken at an acceleration voltage of 80 keV on a Philips CM100 electron
microscope equipped with a FEI Morgagni digital camera and images analyzed
using iTEM software. The numbers of mitochondria per cell and the morphometric
analysis of mitochondria and cristae were carried out as previously described using
the Imaris software10,35,61.
Cell death assay. Cell death was assessed by uptake of ethidium bromide ﬂuor-
escent dye (25 μM) and analyzed by ﬂow cytometer (BD FACSCalibur)2,21,62.
Statistical analysis. Analysis of all data was performed using the Prism software
(GraphPad Software Inc., San Diego, CA, USA). All data are expressed as
the means ± SEM. To compare groups, one-way ANOVA followed by Tukey’s
multiple comparisons test or the Kruskal–Wallis test was applied. Differences
between many groups at two levels were tested by two-way ANOVA followed by
Bonferroni post tests. p values of <0.05 were considered statistically signiﬁcant.
Data availability. All relevant data are available from the authors upon request.
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